Cargando…

Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection

The H7N9 influenza virus has been circulating in China for more than six years. The neuraminidase (NA) has gained great concern for the development of antiviral drugs, therapeutic antibodies, and new vaccines. In this study, we screened seven mouse monoclonal antibodies (mAbs) and compared their pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Fei-Fei, Liu, Xue-Ying, Gao, Fei-Xia, Luo, Jian, Duan, Peng, Tan, Wen-Song, Chen, Ze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968527/ https://www.ncbi.nlm.nih.gov/pubmed/31894728 http://dx.doi.org/10.1080/22221751.2019.1708214

Ejemplares similares

Generation of a recombinant chickenized monoclonal antibody against the neuraminidase of H9N2 avian influenza virus
por: Wang, Fei, et al.
Publicado: (2020)

A Cross-Reactive Monoclonal Antibody Against Neuraminidases of Both H9N2 and H3N2 Influenza Viruses Shows Protection in Mice Challenging Models
por: Wang, Fei, et al.
Publicado: (2021)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
por: Abbadi, Nada, et al.
Publicado: (2023)

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes
por: Wohlbold, Teddy John, et al.
Publicado: (2017)

Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies
por: Piepenbrink, Michael, et al.
Publicado: (2023)

Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding
por: Benton, Donald J., et al.
Publicado: (2017)

A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
por: Yasuhara, Atsuhiro, et al.
Publicado: (2022)

Identification of key residues involved in the neuraminidase antigenic variation of H9N2 influenza virus
por: Wang, Fei, et al.
Publicado: (2021)

Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2022)

Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant
por: Luo, Jian, et al.
Publicado: (2019)

Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
por: Desheva, Yulia, et al.
Publicado: (2022)

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin
por: Yu, Fei, et al.
Publicado: (2017)

A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines
por: Zhao, Hui, et al.
Publicado: (2018)

Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus
por: Ito, Mutsumi, et al.
Publicado: (2019)

Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus
por: Yang, Fan, et al.
Publicado: (2020)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans
por: Rijal, Pramila, et al.
Publicado: (2020)

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
por: Desheva, Yulia, et al.
Publicado: (2018)

Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus
por: Jiang, Haihai, et al.
Publicado: (2020)

A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase
por: Doyle, Tracey M, et al.
Publicado: (2014)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody
por: Chen, Jianjun, et al.
Publicado: (2007)

Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses
por: Wu, Yan, et al.
Publicado: (2013)

Could A Deletion in Neuraminidase Stalk Strengthen Human Tropism of the Novel Avian Influenza Virus H7N9 in China, 2013?
por: Chen, Liang, et al.
Publicado: (2015)

Tetrameric Neuraminidase of Influenza A Virus Is Required to Induce Protective Antibody Responses in Mice
por: Deng, Xiren, et al.
Publicado: (2021)

Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies
por: Kosik, Ivan, et al.
Publicado: (2019)

A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
por: Li, Jingxin, et al.
Publicado: (2022)

Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus
por: Chang, Pengxiang, et al.
Publicado: (2022)

Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility
por: Hai, Rong, et al.
Publicado: (2013)

Influenza virus glycoprotein-reactive human monoclonal antibodies
por: Li, Yanbai, et al.
Publicado: (2020)

Identification of Hemagglutinin Mutations Caused by Neuraminidase Antibody Pressure
por: Wang, Fei, et al.
Publicado: (2021)

A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
por: Marcelin, Glendie, et al.
Publicado: (2011)

Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections
por: Karunarathna, Herath M. T. K., et al.
Publicado: (2019)

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
por: Tran-To Su, Chinh, et al.
Publicado: (2013)

Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains
por: Turner, Hannah L., et al.
Publicado: (2019)

Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
por: Schmeisser, Falko, et al.
Publicado: (2015)

Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
por: Meseda, Clement A., et al.
Publicado: (2018)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
por: Gentles, Lauren E., et al.
Publicado: (2020)

Computational Assay of H7N9 Influenza Neuraminidase Reveals R292K Mutation Reduces Drug Binding Affinity
por: Woods, Christopher J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_phq86o12eu39n1ihrmlhg4rcrn